Information was received from a healthcare provider via a clinical study on 2018-apr-19 regarding a patient receiving baclofen (dose and concentration unknown) via a temporary intrathecal catheter.The indication for use was unknown.It was reported that the temporary intrathecal catheter was placed on (b)(6) 2018, and a broken catheter was identified in fluoroscopy on (b)(6) 2018.The break prevented baclofen flow and cerebrospinal fluid (csf) collection.The break was identified on day 3 of the study and on the first day of catheter movement.It was noted that the catheter was used per protocol for baclofen administration via bolus and withdrawal of csf.No drug was being administered at the time of identification of breakage, and daily fluoroscopy was part of the study protocol.No patient symptoms/sequelae were reported, and no serious adverse events (saes) were associated with the catheter break.The catheter was removed and discarded in medical waste, and the patient was withdrawn from the study.It was noted that the event was possibly related to the implant procedure.The event did not result in any of the following: in-patient hospitalization, prolongation of existing hospitalization, emergency room visit, urgent care visit, or an unscheduled clinic or office visit.No actions were taken associated with this event and it was indicated the event resolved without sequelae.No further complications were reported or anticipated.
|